semaglutide gi obstruction law firm in louisiana gastric intestinal lawsuit lawyer semaglutide in louisiana kentucky semaglutide gastrointestinal tirzepatide attorney in louisiana semaglutide

In the landmark STEP 1 clinical trial, semaglutide produced an average weight loss of approximately 15% of body weight over 68 weeks of treatment

Like obstructions of the small intestine, bowel obstructions could lead to tissue death, peritonitis, or sepsis without proper treatment

GLP-1 receptor agonists like semaglutide affect glucose metabolism, pancreatic function, and inflammation markerschanges that show up in your lab results

Cagrilintide and semaglutide together produce greater weight loss than semaglutide alone

Specialized tests that can detect semaglutide directly While routine labs cannot find semaglutide, specialized assays can